Community/Retail

The FDA has approved sarilumab (Kevzara) from Sanofi and Regeneron Pharmaceuticals for the treatment of adult patients with moderately to severely active rheumatoid arthritis.

In this clip, Jennifer Strohecker, PharmD, BCPS, Sr. Director MHI Pharmacy, Clinical Operations, Molina Healthcare, Inc. discusses the challenges involved in treating patients with hepatitis C.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.